Key result
Primary percutaneous transluminal coronary angioplasty is superior to thrombolytic therapy in reducing mortality, stroke, and reinfarction in acute myocardial infarction.
Why the study?
Does primary percutaneous transluminal coronary angioplasty reduce mortality and morbidity compared to thrombolytic therapy in patients with acute myocardial infarction?
Population
Patients with acute myocardial infarction (specifically ST elevation myocardial infarction)
Comparison
Primary percutaneous transluminal coronary… vs Thrombolytic therapy
Design
Review
Authors
Loading...
Supports primary PCI over thrombolysis in AMI; leaves open impact of modern stents and transfer protocols.
Does primary percutaneous transluminal coronary angioplasty reduce mortality and morbidity compared to thrombolytic therapy in patients with acute myocardial infarction?
Primary percutaneous coronary intervention with routine stenting is superior to thrombolytic therapy for acute myocardial infarction, including for patients requiring transfer to a primary angioplasty center.
Chen et al. (2006) conducted a review in Acute Myocardial Infarction. Primary percutaneous transluminal coronary angioplasty vs. Thrombolytic therapy was evaluated. Primary percutaneous transluminal coronary angioplasty is superior to thrombolytic therapy in reducing mortality, stroke, and reinfarction in acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: